Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide Taken as 5 Days Per Week

NCT06773754 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Virally Suppressed People With HIV

Interventions

OTHER: Five-days-On and Two-days-Off

Sponsor

National Taiwan University Hospital